Company Filing History:
1 out of 7 
1 out of 23 Years Active: 1998
Title: Magali Holuigue: Innovator in Monoclonal Antibodies
Introduction
Magali Holuigue is a prominent inventor based in Samer, France. She has made significant contributions to the field of immunology, particularly in the development of human monoclonal antibodies. Her work is crucial for advancing medical treatments and understanding immune responses.
Latest Patents
Holuigue holds a patent for "Human monoclonal anti-rhesus (D) antibodies and cell lines producing same." This invention relates to two human monoclonal antibodies of subclasses IgG1 and IgG3, specifically targeting the Rhesus D antigen. The pharmaceutical composition she developed is intended for the prophylaxis of hemolytic disease of the newborn. Additionally, her invention includes heterohybridoma cell lines that produce these antibodies, which are filed with the Deutsche Sammlung von Mikroorganismen und Zellkulturen under accession numbers DSM AC 2039 and DSM AC 2040. She has 1 patent to her name.
Career Highlights
Throughout her career, Holuigue has worked with notable organizations, including the Association pour l'Essor de la Transfusion Sanguine dans la Région du and Biotest Pharma GmbH. Her expertise in the field has allowed her to contribute to significant advancements in medical science.
Collaborations
Holuigue has collaborated with esteemed colleagues such as Roland Beliard and Ulf Bethke. These partnerships have further enriched her research and development efforts.
Conclusion
Magali Holuigue's innovative work in monoclonal antibodies has made a lasting impact on the medical field. Her contributions are vital for improving treatments and understanding immune responses.